Glimepiride

DB00222ApprovedInvestigationalSmall moleculeBlood Glucose Lowering AgentsSulfonylureas

Glimepiride is a sulfonylurea drug used to treat type 2 diabetes mellitus. Type 2 diabetes is a metabolic disorder with increasing prevalences worldwide; it is characterized by insulin resistance in accordance with progressive β cell failure and long-term microvascular and macrovascular complications that lead to co-morbidities and...

Chemical structure of Glimepiride
Mechanism
Curator reviewed · 6 references
Primary indication
Glimepiride is indicated for the management of type 2 diabetes in adults as an adjunct to diet and exercise to improve glycemic control as monotherapy.Curator reviewed · 6 structured indications
Formula / weight
C24H34N4O5S · 490.62 g/mol (avg)
First approval
Canada, 2004 · United States, 2000 · European Union, 2016
Code names
HOE-490
Brand names
  • Duetact
  • Tandemact

Resolves to

Structure
InChIKeyWIGIZIANZCJQQY-RUCARUNLSA-NSMILESCCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O
Transporters

What you can answer from here — as of September 23, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
1,376Drug interactionsStructured to mechanism, not free text
Sign in
85Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
4ContraindicationsEach with its own population and attribute set
Sign in
1,377Marketed productsAcross 12 countries and 160 labellers
Sign in
3ATC codesIncluding every combination product, plus 17 drug categories
Sign in
21+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Glimepiride, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account